NCT00015223
Completed
Phase 2
Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cocaine-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Primary Endpoint
- Psychosocial counseling sessions
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.
Detailed Description
The objective of this study is to determine the safety and efficacy of methylphenidate in a population of patients who are cocaine dependent and suffer from attention deficit hyperactivity disorder.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the past 30 days of screening.
Exclusion Criteria
- •Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or benzos. History of seizures.
Outcomes
Primary Outcomes
Psychosocial counseling sessions
Safety assessments
Cocaine use
Methylphenidate retention
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3Cocaine-Related DisordersNCT00015054National Institute on Drug Abuse (NIDA)20
Completed
Phase 1
Cocaine-Methylphendidate Interaction Study - 4Cocaine-Related DisordersNCT00015067National Institute on Drug Abuse (NIDA)8
Completed
Phase 1
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1Attention Deficit Disorder With HyperactivityCocaine-Related DisordersNCT00136734New York State Psychiatric Institute124
Completed
Phase 2
Modafinil for the Treatment of Cocaine Dependence - 1Cocaine-Related DisordersNCT00100100National Institute on Drug Abuse (NIDA)210
Completed
Phase 2
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4Cocaine-Related DisordersSubstance-Related DisordersNCT00015210Boston Medical Center69